# FDA recall D-0745-2022

> **The Ritedose Corporation** · Class III · drug recall initiated 2022-04-01.

## Product

23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930 0

## Reason for recall

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0745-2022
- **Recalling firm:** The Ritedose Corporation
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-01
- **Report date:** 2022-04-13
- **Termination date:** 2022-12-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbia, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0745-2022

## Citation

> AI Analytics. FDA recall D-0745-2022. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0745-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*